B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.39 EUR 1.7%
Market Cap: 36.1m EUR
Have any thoughts about
Biohit Oyj?
Write Note

Biohit Oyj
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biohit Oyj
Cost of Revenue Peer Comparison

Comparables:
R
REG1V
M
MODU
B
BRETEC
O
OPTOMED
N
NXTMH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Biohit Oyj
OMXH:BIOBV
Cost of Revenue
-€5.4m
CAGR 3-Years
-18%
CAGR 5-Years
-11%
CAGR 10-Years
-14%
R
Revenio Group Oyj
OMXH:REG1V
Cost of Revenue
-€47.5m
CAGR 3-Years
-16%
CAGR 5-Years
-30%
CAGR 10-Years
-22%
M
Modulight Oyj
OMXH:MODU
Cost of Revenue
€958k
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Cost of Revenue
-€1.2m
CAGR 3-Years
-44%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Cost of Revenue
-€4.9m
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Cost of Revenue
-€218.7k
CAGR 3-Years
34%
CAGR 5-Years
20%
CAGR 10-Years
N/A

See Also

What is Biohit Oyj's Cost of Revenue?
Cost of Revenue
-5.4m EUR

Based on the financial report for Jun 30, 2024, Biohit Oyj's Cost of Revenue amounts to -5.4m EUR.

What is Biohit Oyj's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-14%

Over the last year, the Cost of Revenue growth was -31%. The average annual Cost of Revenue growth rates for Biohit Oyj have been -18% over the past three years , -11% over the past five years , and -14% over the past ten years .

Back to Top